Aster DM Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare Limited has submitted to the exchanges copies of newspaper clippings containing its unaudited financial results for the quarter ended June 30, 2025. The Board of Directors approved these results on July 30, 2025, and they were reviewed by statutory auditors Deloitte Haskins & Sells. On a consolidated basis, total income from operations rose to ₹2,486.16 crore from ₹2,207.41 crore in the year-ago quarter, a growth of about 12.7%. Net profit after tax jumped sharply to ₹119.57 crore from ₹32.62 crore a year earlier, while basic and diluted EPS increased to ₹15.53 from ₹4.24. On a standalone basis, the company swung to a profit of ₹77.87 crore from a loss of ₹9.17 crore in Q1 FY2025.
This is a routine regulatory filing sharing the newspaper publication of already-approved quarterly results, not a new announcement. The underlying numbers, however, signal a strong year-on-year recovery in profitability and steady revenue growth, which is positive for shareholders tracking the stock's earnings trajectory.